- Home
- KELYA vs REPL Comparison
KELYA vs REPL Comparison
Compare KELYA & REPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KELYA
- REPL
- Stock Information
- Founded
- KELYA 1946
- REPL 2015
- Country
- KELYA United States
- REPL United States
- Employees
- KELYA N/A
- REPL N/A
- Industry
- KELYA Professional Services
- REPL Biotechnology: Pharmaceutical Preparations
- Sector
- KELYA Consumer Discretionary
- REPL Health Care
- Exchange
- KELYA Nasdaq
- REPL Nasdaq
- Market Cap
- KELYA 752.3M
- REPL 897.3M
- IPO Year
- KELYA N/A
- REPL 2018
- Fundamental
- Price
- KELYA $13.02
- REPL $12.49
- Analyst Decision
- KELYA Buy
- REPL Strong Buy
- Analyst Count
- KELYA 1
- REPL 6
- Target Price
- KELYA $25.00
- REPL $17.50
- AVG Volume (30 Days)
- KELYA 1.1M
- REPL 1.3M
- Earning Date
- KELYA 02-13-2025
- REPL 02-06-2025
- Dividend Yield
- KELYA 2.30%
- REPL N/A
- EPS Growth
- KELYA 80.11
- REPL N/A
- EPS
- KELYA 1.16
- REPL N/A
- Revenue
- KELYA $4,372,900,000.00
- REPL N/A
- Revenue This Year
- KELYA N/A
- REPL N/A
- Revenue Next Year
- KELYA $8.21
- REPL $300.41
- P/E Ratio
- KELYA $11.21
- REPL N/A
- Revenue Growth
- KELYA N/A
- REPL N/A
- 52 Week Low
- KELYA $12.68
- REPL $4.92
- 52 Week High
- KELYA $25.27
- REPL $17.00
- Technical
- Relative Strength Index (RSI)
- KELYA 24.76
- REPL 50.53
- Support Level
- KELYA $12.68
- REPL $11.19
- Resistance Level
- KELYA $13.95
- REPL $12.79
- Average True Range (ATR)
- KELYA 0.57
- REPL 0.70
- MACD
- KELYA 0.04
- REPL -0.14
- Stochastic Oscillator
- KELYA 11.22
- REPL 52.21
About KELYA Kelly Services Inc.
Kelly Services Inc is a provider of workforce solutions and consulting and staffing services. The company's operations are divided into five business segments namely Professional & Industrial, Science, Engineering & Technology, Education, Outsourcing & Consulting, and International. Other than OCG, each segment delivers talent through staffing services, permanent placement, or outcome-based services. OCG segment delivers talent solutions including managed service providers, payroll process outsourcing, recruitment process outsourcing, and talent advisory services. International also delivers RPO talent solutions within its local markets. The majority of revenue is derived from Professional & Industrial.
About REPL Replimune Group Inc.
Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3.